Vaccination Stocks List

Vaccination Stocks Recent News

Date Stock Title
Jul 5 CVAC An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued
Jul 5 IBIO iBio files $150M mixed shelf offering
Jul 4 VALN Declaration of shares and voting rights - Valneva SE - June 30, 2024
Jul 4 CVAC CureVac: GSK's Deal For Infectious Disease Assets Is A Long-Shot For Both Pharmas
Jul 4 CVAC GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
Jul 4 CVAC Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
Jul 4 CVAC CureVac announces restructuring to focus on mRNA projects
Jul 3 CVAC GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines
Jul 3 CVAC GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
Jul 3 CVAC Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Jul 3 CVAC Biggest stock movers today: Electric vehicle stocks, PARAA, CVAC, and more
Jul 3 EVAX Evaxion Reinforces Milestone Timeline and Provides Shareholder Update
Jul 3 CVAC GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Jul 3 CVAC GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion
Jul 3 CVAC CureVac cuts jobs, licenses out vaccines to GSK
Jul 3 CVAC GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion
Jul 3 CVAC GSK and CureVac restructure mRNA vaccine development deal
Jul 3 CVAC CureVac Enters Into New Licensing Agreement With GSK; to Implement 'Significant' Restructuring; Shares Rise Pre-Bell
Jul 3 CVAC CureVac to cut 30% of workforce as GSK buys rights to make flu, covid shots
Jul 3 CVAC CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
Vaccination

Vaccination is the administration of antigenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. The effectiveness of vaccination has been widely studied and verified. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio, measles, and tetanus from much of the world.
Smallpox was most likely the first disease people tried to prevent by inoculation and was the first disease for which a vaccine was produced. The smallpox vaccine was invented in 1796 by English physician Edward Jenner and although at least six people had used the same principles years earlier he was the first to publish evidence that it was effective and to provide advice on its production. Louis Pasteur furthered the concept through his work in microbiology. The immunization was called vaccination because it was derived from a virus affecting cows (Latin: vacca 'cow'). Smallpox was a contagious and deadly disease, causing the deaths of 20–60% of infected adults and over 80% of infected children. When smallpox was finally eradicated in 1979, it had already killed an estimated 300–500 million people in the 20th century.
In common speech, vaccination and immunization have a similar meaning. This distinguishes it from inoculation, which uses unweakened live pathogens, although in common usage either can refer to an immunization. Vaccination efforts have been met with some controversy on scientific, ethical, political, medical safety, and religious grounds. In rare cases, vaccinations can injure people. In the United States, people may receive compensation for those injuries under the National Vaccine Injury Compensation Program. Early success brought widespread acceptance, and mass vaccination campaigns have greatly reduced the incidence of many diseases in numerous geographic regions.

Browse All Tags